Wells Fargo’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Wells Fargo’s Portfolio MKUL Stock Details MKUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-129	Closed	-$19	–	7832
2023 Q3	$19	Sell	129 -40	-24%	-$59	﹤0.01%	7229
2023 Q2	$395	Buy	169 +7	+4%	+$13	﹤0.01%	6538
2023 Q1	$274	Buy	162 +104	+179%	+$269	﹤0.01%	6692
2022 Q4	$182	Buy	58 +2	+4%	+$7	﹤0.01%	6643
2022 Q3	$0	Buy	56 +36	+180%	+$217	﹤0.01%	7692
2022 Q2	$0	Buy	20 +1	+5%	+$6	﹤0.01%	7797
2022 Q1	$0	Buy	+19	New	+$98	﹤0.01%	8128

Other funds holding MKUL

FGN

Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SFG

SVB Financial Group Dallas, Texas $434K AUM 277.67% 1-Year Est. Return

Wells Fargo's MKUL Position: Q4 2023 in Review

Wells Fargo sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 129 shares — an estimated $19 sold.

Wells Fargo first reported a position in MKUL in Q1 2022 and held it in 7 quarters. The position peaked at $395 in Q2 2023. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

Wells Fargo reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 129 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $19.
Wells Fargo first reported a position in Molekule Group, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Wells Fargo's Molekule Group, Inc. Common Stock position peaked at $395 in Q2 2023.
3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.